BioLife SolutionsBLFS +4.25%72 Median PS Value is $24.93 as of Jun. 27, 2026, which is 1333% above its 10-year median of 1.74. GuruFocus rates BLFS with a GF Score™ of 72/100 and a GF Value™ of $28.57 (Fairly Valued). The stock has 5 warning signs investors should review. Among 338 Medical Devices & Instruments companies, BioLife Solutions ranks worse than 81.07% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for BioLife Solutions's Median PS Value or its related term are showing as below:
BLFS'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.69 Med: 1.74 Max: 5.33
Current: 1.15
During the past 13 years, the highest Price to Median PS Value of BioLife Solutions was 5.33. The lowest was 0.69. And the median was 1.74.
BLFS's Price-to-Median-PS-Value is ranked worse than 81.07% of 338
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs BLFS: 1.15
BioLife Solutions (NAS:BLFS) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
BioLife Solutions's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
28.64
/
24.93
=
1.15
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioLife Solutions Median PS Value Related Terms
BioLife Solutions Median PS Value Historical Data
* Premium members only.
The historical data trend for BioLife Solutions's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BLFS vs KMTS, AZTA, ATRC: Median PS Value Comparison
For the Medical Instruments & Supplies subindustry, BioLife Solutions's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioLife Solutions Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where BioLife Solutions's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 12.2868.
BioLife Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.029.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioLife Solutions (BLFS) has a Median PS Value of $24.93 as of Jun. 27, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on BioLife Solutions and its competitors. This is 1333% above median its historical median of 1.74. Over the past decade, BioLife Solutions' Median PS Value has ranged from 0.69 to 5.33. According to the industry distribution chart, BioLife Solutions ranks #274 out of 338 companies in the Medical Devices & Instruments industry, placing it in the top 81.1%.
Is BioLife Solutions' Median PS Value too high?
BioLife Solutions' current Median PS Value of $24.93 is 1333% above median its 10-year median of 1.74. Over the past 10 years, this metric has ranged from a low of 0.69 to a high of 5.33. The Medical Devices & Instruments industry median Median PS Value is 0.71. BioLife Solutions' value of $24.93 is 3411.3% above this industry median. Based on the distribution chart, BioLife Solutions ranks #274 out of 338 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, BioLife Solutions has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BioLife Solutions' Median PS Value compare to KMTS and AZTA?
According to the Medical Devices & Instruments industry distribution chart, BioLife Solutions ranks #274 out of 338 companies for Median PS Value. This places BioLife Solutions in the lower half of its industry. The industry median Median PS Value is 0.71. BioLife Solutions' value of $24.93 is 3411.3% above this benchmark. Historically, BioLife Solutions' own Median PS Value has ranged from 0.69 to 5.33 over the past decade. While the company's 10-year median is 1.74 vs. the industry median of 0.71, BioLife Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 338 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioLife Solutions's current Median PS Value of $24.93 is 3411.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on BioLife Solutions and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioLife Solutions's current Median PS Value is $24.93, which is 1333% above median its own 10-year median of 1.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioLife Solutions stock overvalued right now?
Based on GuruFocus' analysis, BioLife Solutions (BLFS) is currently considered Fairly Valued. The stock's GF Value™ is $28.57, compared to a current price of $28.64 — trading 0.2% above its estimated fair value. The current Median PS Value is $24.93, which is 1333% above median its 10-year median of 1.74 and 3411.3% above the Medical Devices & Instruments industry median of 0.71. BioLife Solutions' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For BioLife Solutions (BLFS), the current Median PS Value is $24.93 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioLife Solutions (BLFS) Overvalued in 2026?
Based on GuruFocus' analysis, BioLife Solutions stock appears to be overvalued.
The current stock price of $28.64 is trading 0.2% above its estimated GF Value™ of $28.57.
GuruFocus considers BioLife Solutions to be Fairly Valued.
Key valuation signals for BLFS:
Median PS Value: $24.93 (1333% above median its 10-year median of 1.74)
GF Value™: $28.57 vs. price of $28.64 (0.2% above fair value)
Industry Position: 3411.3% above the Medical Devices & Instruments median (#274 of 338)
No single metric tells the full story. See the BLFS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
72GF Score
Get the complete analysis for BLFS
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLFS has been successfully added to your 
